AI-Powered chest X-Rays could revolutionize lung cancer screening in latin america

NCT ID NCT07524803

Not yet recruiting Diagnosis Sponsor: Latin American Consortium for the Lung Cancer Research Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will enroll 2,000 people aged 50 or older in Mexico, Costa Rica, Colombia, and Argentina who are at high risk for lung cancer due to smoking, wood smoke exposure, family history, or COPD. Participants will get a chest X-ray analyzed by artificial intelligence and a low-dose CT scan to see if the AI can help decide who needs follow-up scans. The goal is to improve early detection of lung nodules in a region where screening guidelines are still being developed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Low-dose CT scan and chest X-ray with AI analysis
What this could lead to: If successful, this could show that combining AI with chest X-rays helps identify who needs a CT scan, making lung cancer screening more accessible in Latin America.
What could go wrong: This is an observational study, not a treatment trial. It may not prove that screening saves lives, and results may not apply to other regions or risk groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER SCREENING

Contacts and locations

Locations

CTIC

Bogotá, Colombia
Centro de Investigacion y Manejo del Cancer (CIMCA)

San José, Provincia de San José, 10103, Costa Rica

More trials for these conditions

Other studies related to the condition(s) this trial covers.